Who owns Checkpoint Therapeutics Inc Com New?
- Ticker: CKPT
- CUSIP Number: 162828206
Tip: Access positions for across all investors
Analyze quarterly positions in Checkpoint Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Checkpoint Therapeutics stock
Who bought or sold Checkpoint Therapeutics Inc Com New this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Armistice Capital | 2.7M | $5.6M | 32% | Mar 2024 |
|
| Vanguard Group | 918k | $1.9M | 67% | Mar 2024 |
|
| Susquehanna International | 241k | $495k | 220% | Mar 2024 |
|
| Geode Capital Management | 199k | $407k | 15% | Mar 2024 |
|
| Citadel Advisors | 169k | $347k | 96% | Mar 2024 |
|
| BlackRock | 165k | $339k | 60% | Mar 2024 |
|
| Advisor Group Holdings | 135k | $277k | -17% | Mar 2024 |
|
| Pvg Asset Management | 115k | $264k | 4% | Dec 2023 |
|
| D. E. Shaw & Co | 109k | $223k | -23% | Mar 2024 |
|
| Legacy Wealth Asset Management | 85k | $174k | 0% | Mar 2024 |
|
| Envestnet Asset Management | 77k | $157k | 59% | Mar 2024 |
|
| Millennium Management | 63k | $130k | 432% | Mar 2024 |
|
| Royal Bank of Canada | 61k | $195k | 0% | Mar 2024 |
|
| Park Avenue Securities | 60k | $123k | 0% | Mar 2024 |
|
| Rsm Us Wealth Management | 58k | $119k | 201% | Mar 2024 |
|
| Wealth Enhancement Advisory Services | 50k | $103k | -41% | Mar 2024 |
|
| National Asset Management | 49k | $84k | -70% | Mar 2024 |
|
| Northern Trust | 43k | $89k | 61% | Mar 2024 |
|
| Lindbrook Capital | 30k | $62k | 100% | Mar 2024 |
|
| Magnus Financial Group | 30k | $62k | 100% | Mar 2024 |
|
| Cetera Investment Advisers | 24k | $50k | 38% | Mar 2024 |
|
| Titleist Asset Management | 18k | $36k | 100% | Mar 2024 |
|
| Emfo | 16k | $32k | 0% | Mar 2024 |
|
| Ironwood Investment Management | 13k | $26k | 9% | Mar 2024 |
|
| Apollon Wealth Management | 12k | $24k | 100% | Mar 2024 |
|
| CIBC Global Asset Management | 11k | $23k | 0% | Mar 2024 |
|
| Morgan Stanley | 11k | $43k | 54% | Mar 2024 |
|
| Raymond James Financial Services Advisors | 11k | $22k | 100% | Mar 2024 |
|
| Ark & Tlk Investments | 10k | $21k | 0% | Mar 2024 |
|
| Gladstone Institutional Advisory | 10k | $23k | 100% | Dec 2023 |
|
| Tower Research Capital | 7.2k | $15k | 25% | Mar 2024 |
|
| Bartlett & Co. Wealth Management | 4.0k | $8.2k | 0% | Mar 2024 |
|
| Bartlett & Co. | 4.0k | $9.0k | -20% | Dec 2023 |
|
| Wells Fargo & Company | 3.2k | $6.5k | -82% | Mar 2024 |
|
| UBS Group | 1.5k | $3.1k | -2% | Mar 2024 |
|
| TSFG | 300.00 | $999.990000 | 0% | Mar 2024 |
|
| Householder Group Estate & Retirement Specialist | 200.00 | $410.000000 | -33% | Mar 2024 |
|
| FMR | 150.00 | $307.995000 | 2900% | Mar 2024 |
|
| VisionPoint Advisory Group | 100.00 | $205.000000 | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 1.00 | $2.000000 | 0% | Mar 2024 |
|
Who sold out of Checkpoint Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jane Street | Dec 2023 | 41k | $93k |
| Goss Wealth Management | Sep 2023 | 30k | $51k |
| XTX Topco | Sep 2023 | 21k | $36k |
| Two Sigma Securities | Dec 2023 | 14k | $32k |
| Simplex Trading | Dec 2023 | 14k | $31k |
| Hrt Financial | Dec 2023 | 13k | $30k |
| Squarepoint Ops | Dec 2023 | 12k | $27k |
| Bank of America Corporation | Dec 2023 | 25.00 | $57.692500 |